| Record ID | marc_loc_2016/BooksAll.2016.part36.utf8:91598204:1451 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part36.utf8:91598204:1451?format=raw |
LEADER: 01451cam a2200445 a 4500
001 2008940944
003 DLC
005 20141113075116.0
008 081103s2009 nyuaf b 001 0 eng c
010 $a 2008940944
015 $aGBA891184$2bnb
016 7 $a101502391$2DNLM
016 7 $a014674471$2Uk
020 $a9781603273060 (alk. paper)
020 $a1603273069 (alk. paper)
020 $a9781603278799 (ebk.)
020 $a1603278796 (ebk.)
035 $a(OCoLC)ocn233933790
040 $aNLM$cNLM$dUKM$dBTCTA$dBAKER$dYDXCP$dBWX$dWYU$dCUS$dVRC$dDLC
042 $apcc
050 00 $aRC268.4$b.T45 2009
060 00 $a2009 D-964
060 10 $aQZ 202$bT277 2009
082 00 $a362.196/994$222
245 00 $aTelomeres and telomerase in cancer /$cKeiko Hiyama, editor.
260 $aNew York :$bSpringer,$cc2009.
300 $axii, 373 p., [18] p. of plates :$bill. ;$c24 cm.
490 1 $aCancer drug discovery and development
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xMolecular aspects.
650 0 $aTelomerase.
650 0 $aTelomere.
650 12 $aCell Transformation, Neoplastic.
650 12 $aTelomere$xgenetics.
650 22 $aAntineoplastic Agents$xtherapeutic use.
650 22 $aNeoplasms$xdrug therapy.
650 22 $aTelomerase$xantagonists & inhibitors.
650 22 $aTelomere-Binding Proteins.
700 1 $aHiyama, Keiko.
830 0 $aCancer drug discovery and development.